COCHLEAR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.6 AUD | +0.83% |
|
+0.47% | +8.00% |
| 05-29 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
| 05-21 | Cochlear Completes Acquisition of Oticon Medical's Cochlear Implant Business | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.28B 1.51B 119B | Sales 2025 * | 2.5B 1.66B 130B | Capitalization | 21.13B 14.05B 1,103B |
|---|---|---|---|---|---|
| Net income 2024 * | 392M 261M 20.47B | Net income 2025 * | 444M 295M 23.18B | EV / Sales 2024 * | 9.05 x |
| Net cash position 2024 * | 523M 348M 27.32B | Net cash position 2025 * | 580M 386M 30.27B | EV / Sales 2025 * | 8.23 x |
| P/E ratio 2024 * |
54
x | P/E ratio 2025 * |
48.1
x | Employees | 4,800 |
| Yield 2024 * |
1.29% | Yield 2025 * |
1.48% | Free-Float | 99.37% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cochlear Limited
More recommendations
| 1 day | +0.83% | ||
| 1 week | +0.47% | ||
| 1 month | +1.70% | ||
| 3 months | -4.14% | ||
| 6 months | +18.46% | ||
| Current year | +8.00% |
1 week
311.66
326.52
1 month
311.66340.56
Current year
283.70350.17
1 year
220.40350.17
3 years
178.55350.17
5 years
154.60350.17
10 years
58.51350.17
| Managers | Title | Age | Since |
|---|---|---|---|
Diggory Howitt
CEO | Chief Executive Officer | - | 31/12/99 |
Catriona Deans
CHM | Chairman | 56 | 31/01/15 |
Stuart Sayers
DFI | Director of Finance/CFO | - | 30/04/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Daniell
BRD | Director/Board Member | 66 | 31/12/19 |
Glen Boreham
BRD | Director/Board Member | 60 | 31/12/14 |
| Director/Board Member | 60 | 31/10/20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.14% | 14 M€ | -5.07% | ||
| 0.69% | 120 M€ | +1.02% | - | |
| 0.35% | 2 M€ | -.--% | - | |
| 0.35% | 2 M€ | +9.19% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/05/24 | 322.6 | +0.83% | 436,906 |
| 30/05/24 | 319.9 | +1.71% | 85,088 |
| 29/05/24 | 314.6 | -1.70% | 153,960 |
| 28/05/24 | 320 | -1.51% | 118,445 |
| 27/05/24 | 324.9 | +1.21% | 78,850 |
Delayed Quote Australian S.E., May 31, 2024 at 07:10 am
More quotes
Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Companyâs products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Calendar
14/08/2024
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
16
Last Close Price
322.6
AUD
Average target price
280.9
AUD
Spread / Average Target
-12.90%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +8.00% | 14.03B | |
| -13.72% | 20.65B | |
| +3.79% | 18.79B | |
| -20.38% | 1.99B | |
| +3.10% | 1.76B | |
| +8.31% | 1.33B | |
| +6.05% | 552M | |
| -.--% | 421M | |
| +69.47% | 196M | |
| +11.28% | 88.9M |
- Stock Market
- Equities
- COH Stock
